DNA X, Inc. (SONM) Operating margin 2018–2024
DNA X, Inc. (SONM) operating margin by fiscal year — reported operating income divided by reported revenue.
-6.1%FY2024 · since FY2018: 4.0% → -6.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -6.1% | -6.6 pp |
| FY2023 | 0.5% | +21.0 pp |
| FY2022 | -20.5% | +49.2 pp |
| FY2021 | -69.6% | -23.9 pp |
| FY2020 | -45.7% | -26.5 pp |
| FY2019 | -19.3% | -23.2 pp |
| FY2018 | 4.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice